Skip to main navigation Skip to search Skip to main content

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry

Research output: Contribution to journalArticleAcademicpeer-review

38 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2449-2451
Number of pages3
JournalLeukemia
Volume29
Issue number12
DOIs
Publication statusPublished - 2015

Research programs

  • EMC MM-02-41-03

Cite this